project id: TCGA-BRCA; case submitter id: TCGA-B6-A1KI; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 8.2; spectrophotometer method: UV Spec; age at index: 63; days to birth: -23031; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1940; age at diagnosis: 23031; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1c; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2236.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2003; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 2634; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-B6-A1KI-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 2.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 18.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;